Pharmafile Logo
Pharmafocus logo
Advanced Search
biogen_logo

Revenues up at Biogen – but job losses planned

October 22, 2015
Biogen, financial results, job losses, redundancies

Despite lower than predicted sales of its top-selling products, Biogen has achieved $2.8 billion in revenues in the third quarter …

News
Biogen image

Biogen’s natalizumab fails Phase III endpoints

October 21, 2015
Biogen, multiple sclerosis

Biogen’s natalizumab has failed to achieve clinical endpoints in a late-stage study to prove the drug’s potential in patients with …

News
Stelera

Encouraging late-stage results for Stelara in Crohn’s disease

October 21, 2015
Research and Development, Sales and Marketing Crohn’s disease, Janssen, Stelera, crohn's disease, ustekinumab

Janssen is planning new regulatory submissions for Stelera after Phase III data found it improved responses and remission rates in …

News
heather_grant

DNA expands in London, appointing Heather Grant to lead new division

October 21, 2015
Medical Communications

DNA’s well-established medical communications practice will now offer fully integrated healthcare communications to its clients. Neil Flash remains DNA’s managing …

Appointment
heather_grant

DNA expands in London, appointing Heather Grant to lead new division

October 21, 2015
Medical Communications

DNA’s well-established medical communications practice will now offer fully integrated healthcare communications to its clients. Neil Flash remains DNA’s managing …

News
kidney

Featured Market Report – Kidney Disease Global Clinical Trials Review

October 21, 2015
Research and Development

GlobalData’s “Kidney Disease Global Clinical Trials Review, H2, 2015″ gives invaluable insight into the current state of clinical trials in …

Feature

Global warning for governments to step up R&D spending

October 21, 2015
Research and Development

Countries should step up their investment in long-term R&D to develop disruptive technologies that will reshape industry, healthcare and communications, …

News
Ezetrol

NICE issues draft guidance for MSD’s Ezetrol

October 21, 2015
Sales and Marketing MSD, NICE, cardiovascular disease, ezetimibie, ezetrol, high cholesterol

NICE has published draft guidance recommending MSD’s Ezetrol as an option for some adults with high cholesterol.  The guidance updates …

News
Humira

Future Focus: The industry’s top five biggest drug patent expirations in 2016

October 21, 2015
Manufacturing and Production, Research and Development biosimilars, blockbuster, generics, patent cliff, patents

From Humira to Cubicin, some multi-billion dollar drugs are set to be hit hard by patent expiries next year, and …

Feature
novartis_pic

Novartis acquires Admune Therapeutics

October 21, 2015
Research and Development Admune Therapeutics, Cancer, Novartis, Palobiofarma, immunotherapy

Novartis is broadening its portfolio of cancer immunotherapies with the acquisition of Admune Therapeutics, and signing licensing agreements with Palobiofarma …

News
nhs_sign

NHS research activity on the rise

October 21, 2015
Research and Development

NHS England has achieved a significant increase in clinical research over the last year, according to new data from The …

News
Valeant logo

Valeant announces strong Q3 results, will expand US contact lens plant

October 20, 2015
Manufacturing and Production, Sales and Marketing Valeant, financial results, manufacturing, production

Valeant has announced plans to invest up to $150 million and add 200 jobs at its Bausch and Lomb plant …

News
Sprout sign

‘Female Viagra’ goes on sale in the US

October 20, 2015
Addyi, HSDD, Sprout, female viagra, flibanserin, hypoactive sexual desire disorder

The pill dubbed the female version of Viagra – Sprout Pharmaceuticals’ Addyi – has gone on sale in the US. …

News
Daiichi Sankyo

Daiichi sheds more US jobs as generic losses take their toll

October 20, 2015
Daiichi, Daiichi Sankyo, generic competition, generics, job losses, patent cliff, patents, redundancies

The Japan-based drugmaker Daiichi Sankyo is to cut up to 1,200 jobs – or about half its workforce – in …

News
dominaix_scientist

Domainex and Imperial College London partner on heart attack treatments

October 20, 2015
Research and Development Domainex cardiac arrest

Drug discovery company Domainex and Imperial College London have announced a new partnership aimed at discovering novel therapies to treat …

News

Synergy Vision expands global presence to meet demand in the Asia-Pacific region

October 20, 2015
Medical Communications Asia-Pacific, Australia, Sydney, Synergy Vision, asia pacific, medical communcations

UK-based Synergy Vision opens a new office in Sydney, Australia, to meet the demands of their clients across the Asia-Pacific …

News
Press release

Recall after mislabelling of Medline Industries’ drugs

October 20, 2015
Manufacturing and Production US, acetaminophen, paracetamol, product recall

Medline Industries is voluntarily carrying out a nationwide recall of the painkiller acetaminophen, due to a labelling error on the …

News
China manufacturing

China’s Tianjin invests $300m in Ebola plant

October 20, 2015
Manufacturing and Production China, Ebola, Ebola vaccine, manufacturing, production, vaccines

China’s Tianjin CanSino Biotechnology, a developer of affordable vaccines, says that it will invest 2 billion Yuan (£203.3 million) in …

News
DNA

UK ‘is the best place in the world to do big data’, says AAR lead

October 20, 2015
Manufacturing and Production Accelerated Access Review, Big Data, Professor Sir John Bell

The UK is leading the world in developing new drugs from the analysis of big data, according to a leading …

News
nuevolution_logo

Nuevolution, Johnson & Johnson begin discovery collaboration

October 19, 2015
Manufacturing and Production, Research and Development Chemetics, Janssen Biotech, Nuevolution

Nuevolution and Janssen Biotech have entered into a collaboration which will use Nuevolution’s Chemetics drug discovery platform to facilitate discovery …

News
The Gateway to Local Adoption Series

Latest content

Study explores genomic testing approach for unexplained infertility

May 14, 2026

Celtic Renewables receives £7m to develop bio-based solvents

May 14, 2026

Synnovis and SOPHiA GENETICS expand liquid biopsy testing in NHS cancer care

May 13, 2026

MHRA to establish Northern Ireland hub for life sciences sector

May 13, 2026

Shilpa Medicare signs manufacturing deal with NXI Therapeutics

May 12, 2026